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Abstract
Background: As the emphasis in health reform shifts to value-based payments, especially through multi-payer
initiatives supported by the U.S. Center for Medicare & Medicaid Innovation, and with the increasing availability of
statewide all-payer claims databases, the need for an all-payer, “whole-population” approach to facilitate the
reporting of utilization, cost, and quality measures has grown. However, given the disparities between the different
populations served by Medicare, Medicaid, and commercial payers, risk-adjustment methods for addressing these
differences in a single measure have been a challenge.
Methods: This study evaluated different levels of risk adjustment for primary care practice populations – from basic
adjustments for age and gender to a more comprehensive “full model” risk-adjustment method that included
additional demographic, payer, and health status factors. It applied risk adjustment to populations attributed to
patient-centered medical homes (283,153 adult patients and 78,162 pediatric patients) in the state of Vermont that
are part of the Blueprint for Health program. Risk-adjusted expenditure and utilization outcomes for calendar year
2014 were reported in 102 adult and 56 pediatric primary-care comparative practice profiles.
Results: Using total expenditures as the dependent variable for the adult population, the r2 for the model adjusted
for age and gender was 0.028. It increased to 0.265 with the additional adjustment for 3M Clinical Risk Groups and
to 0.293 with the full model. For the adult population at the practice level, the no-adjustment model had the
highest variation as measured by the coefficient of variation (18.5) compared to the age and gender model (14.8);
the age, gender, and CRG model (13.0); and the full model (11.7). Similar results were found for the pediatric
population practices.
Conclusions: Results indicate that more comprehensive risk-adjustment models are effective for comparing cost,
utilization, and quality measures across multi-payer populations. Such evaluations will become more important for
practices, many of which do not distinguish their patients by payer type, and for the implementation of incentive-
based or alternative payment systems that depend on “whole-population” outcomes. In Vermont, providers,
accountable care organizations, policymakers, and consumers have used Blueprint profiles to identify priorities and
opportunities for improving care in their communities.
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Background
In order to achieve the triple aim of improving health
outcomes across a population, improving the experience
of care, and reducing health care costs, [1] the U.S. Cen-
ter for Medicare & Medicaid Innovation (CMMI) at the
Centers for Medicare and Medicaid Services (CMS) is
implementing value-based Advanced Payment Models
that reward health outcomes rather than volume of ser-
vices. The expansion of these models offered through ac-
countable care organizations (ACOs) increasingly
emphasizes multi-payer involvement, primary care fo-
cused on comprehensive patient-centered care, account-
ability for outcomes of a whole population, and use of
population-level data for care management, comparative
evaluation, and performance-based payments [2, 3].
However, in the United States, a complex web of
health insurers has developed over time. These include
Medicare, which covers individuals over the age of 65 as
well as disabled people under 65; Medicaid, which covers
lower income individuals and families; and commercial
insurers, which cover insured people under 65 and their
families. This system has complicated analysis as data
are often stored in isolation and contain variation in
quality, services, and prices. Some of these challenges
can be overcome through development of all-payer
claims databases (APCDs), which facilitate a higher level
of uniformity. Additionally, CMMI has awarded State
Innovation Model (SIM) grants to support investment in
health data infrastructure that facilitates data aggrega-
tion and consistent measurement across different payers
and settings, including practices, hospitals, health service
areas (HSAs), and ACOs [4, 5]. However, analytic
methods that evaluate “whole-population” outcomes
while accounting for diversity among subgroups are
needed to meet the demands of Advanced Payment
Models.
First, these methods require access to multi-payer
data. Efforts to develop statewide APCDs began more
than a decade ago and have expanded significantly in re-
cent years. Currently, 18 states have existing APCDs or
are in the process of implementing these critical re-
sources. Additionally, 22 states have expressed strong
interest in APCDs, and four have voluntary databases;
only six states have no APCD-related activity [6]. Sixteen
states have legislation enabling collection of claims data
[7]. APCDs typically collect eligibility and all-setting
claims and pharmacy data for residents of the state from
commercial payers and often Medicare and Medicaid
data sources. The data are used to generate a wide var-
iety of cost, utilization, and quality measures.
Second, these methods need to support a “whole-
population” measurement system that reports on the
whole population while adequately adjusting for differ-
ences across practices and across their patient
populations. With increased emphasis on primary care
transformation as foundational for an accountable health
system and with the expanded availability of all-payer
data, practices and state initiatives need to understand
how practice transformation is affecting care and patient
health.
Provider and primary care practice profiles are tools
often used to assess a provider’s or practice’s perform-
ance, and a variety of efforts have been made to ad-
dress issues related to risk adjustment, measures
standardization, and comparability across practices
[8–13]. In addition, guidelines for profiling identified by
organizations representing physicians, [14, 15] highlight
the importance of providing consistent measurement and
information across an entire practice population instead
of single-payer reports that cover only a portion of the
practice’s population and use varying measures standards
and methods of risk adjustment.
The state of Vermont has tackled many of the chal-
lenges of building an accountable health system. Its
Blueprint for Health (Blueprint) program is charged with
reforming health care delivery through supporting prac-
tices as they transform to patient-centered medical
homes (PCMHs), supporting multi-disciplinary commu-
nity health teams bridge medical and social services,
implementing per patient per month payment reforms,
and using data to drive quality improvement at multiple
levels – practice, organization, HSA, and state [16]. With
access to the state’s APCD, which includes expenditure,
utilization, and quality data from commercial, Medicaid,
and Medicare payers, as well as clinical data from elec-
tronic medical records, the Blueprint has developed
practice profiles for each PCMH’s “whole population” of
patients. These profiles use a single measurement system
with large sample sizes and a consistent method of mea-
sures generation, risk adjustment, and measurement of
error in estimates. The result is a profile that evaluates a
medical home’s whole patient population through claims
and clinical data and compares outcomes to other med-
ical homes, HSAs, and the state.
This study describes the creation of these provider-
specific reports. Specifically, it describes the risk adjust-
ment and other methods developed to evaluate whole
populations. Beyond providing meaningful information
to the practices, this study, in achieving its aim, also
contributes to the ongoing discussion of how to assess
the effect of alternative payment methods on realizing
an accountable health system and the Triple Aim.
Methods
Data sources
The data used to generate cost, utilization, and quality
measures and risk-adjustment methods for Blueprint
practice profiles includes membership and claims data
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reported to the state’s APCD, the Vermont Health Care
Uniform Reporting & Evaluation System (VHCURES).
The data contained services incurred during calendar
year 2014 by Vermont residents enrolled in commercial
health plans, Medicaid enrollees for whom Medicaid was
the primary payer, and Medicare fee-for-service benefi-
ciaries for whom Medicare was the primary payer. Each
member was attributed to a Blueprint primary care prac-
tice using a consistent cross-payer methodology that
used the plurality of primary care visits based on Evalu-
ation and Management (E&M) codes over a 24-month
look-back period. Because patients may have visited dif-
ferent practitioners within the same primary care prac-
tice group, attribution was made at the practice level.
The APCD data was used to generate a wide range of
claims-based cost, utilization, and quality measures.
Each practice was compared to all Blueprint practices in
the practice’s geographic (HSA) and to all practices
across the state. Practice-level data is not publically
available but practice data rolled-up to HSA level is pub-
lically reported [17].
Methods of risk adjustment
Stratification of pediatric & adult populations
Two types of primary care practice measure sets and
profiles were generated: adult (ages 18 years and older)
and pediatric (ages 1–17 years). The adult profiles in-
cluded members with commercial, Medicaid (ages 18–
64 years), or Medicare (ages 18 years and older) as
primary payer. The pediatric profiles included members
ages 1–17 years with commercial payers or Medicaid as
primary.
While many practices treat both adult and pediatric
populations, others treat primarily only adults or chil-
dren. Because the pediatric and adult populations have
very different health, utilization, and cost distributions,
segregating profiles by adult and pediatric populations
provides a more accurate look at practice differences.
An alternative — basing practice profiles on physician
specialty — would be problematic since attribution is at
the practice level and practice groups may have included
practitioners with different primary care specialties.
Newborn infants under the age of 1 year were not in-
cluded since they (1) have high cost compared to the re-
mainder of the pediatric population, (2) have a small
number of outlier cases requiring neonatal intensive
care, and (3) are often reported as bundled newborn
claims by payers resulting in incomplete reporting of
expenditures.
Treatment of outliers
The method used in this study capped outliers in
expenditure and utilization at the 99th percentile of pa-
tients for each measure. Capping was done at the state-
level for each major payer type (i.e., commercial, Medic-
aid, Medicare), and capped values were used for
practice-level analysis. For the 2014 study population,
the dollars truncated by capping represented 7% for the
adult population and 13% for the pediatric population.
Adjustment for demographics & health status
Demographic and health status information determined
from the APCD data formed the basis for the risk-
adjustment methods used for the Blueprint Practice Pro-
files. These factors included age, gender, presence of a
Blueprint-selected chronic condition, health status as
measured by 3M Clinical Risk Groups (CRGs), and (for
adult profiles) the occurrence of a maternity diagnosis.
Adjustments were made for the partial length of en-
rollment in payer insurance reported for some members
during the calendar year. Average members — i.e., cu-
mulative member months divided by 12 — were re-
ported for each practice.
For the purposes of risk adjustment and to facilitate
interpretation of results, member age was grouped. Due
to the potential for interaction effects of age and gender,
the full model used age and gender groupings (e.g.,
males aged 18–34 years, females aged 18–34, etc.).
There are several systems for measuring health status
being used in the United States, each with its different
point of emphasis, yet no single system has emerged as
the “gold standard.” In this study, the primary method of
adjustment for each member’s health status was based
on the application of 3M Clinical Risk Groups (CRGs)
to the APCD data. CRGs used to measure health status
are applicable to all ages, are updated regularly, are de-
signed for use with claims data, are transparent in docu-
mentation, perform as well as other available systems,
and represent a practical solution to meet the needs of
the Blueprint project [18]. The grouper classifies each
member into a hierarchy of 1080 distinct clinical groups
and nine major clinical CRG statuses based on the diag-
noses reported. Due to small numbers, and to create an
efficient model that was easily understood, these nine
categories were further combined during the risk model
development process into (1) Healthy (reference group),
(2) Acute or Minor Chronic (e.g., acute ear, nose, or
throat condition or minor join pain), (3) Moderate
Chronic (e.g., diabetes or moderate chronic joint pain),
(4) Significant Chronic (e.g., diabetes with other comor-
bid conditions such as congestive heart failure (CHF) or
chronic obstructive pulmonary disease (COPD)), and (5)
Cancer or Catastrophic (e.g., malignant breast cancer,
HIV, cystic fibrosis, muscular dystrophy, quadriplegia).
The Blueprint program also targeted select chronic
conditions: asthma, chronic obstructive pulmonary dis-
order (COPD), congestive heart failure (CHF), depres-
sion, diabetes, hypertension, ischemic heart disease, and
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attention deficit disorder (pediatric model only). A
“chronic” (0/1) variable was created if a member was
identified with any of these conditions. Since CRGs do
not include pregnancy and child birth in clinical classifi-
cation, a “maternity” (0/1) variable was created for mem-
bers with pregnancy or delivery claims during the year.
Adjustment for practice’s Medicaid & Medicare population
The primary care practice profiles combine the popula-
tions from three different payer types (or “payers”) —
commercial, Medicaid, and Medicare — that have
significant differences in demographics, socioeconomic
status, health status, provider reimbursement structures,
and services covered and used. For the full model,
Medicaid members were identified in the indicator vari-
able as: Commercial = 0, Medicare = 0, Medicaid = 1.
Another distinguishing attribute of the Medicaid data
was the inclusion of members who received “special Me-
dicaid services” (SMS) uncommon in the commercial
and Medicare populations. Members receiving SMS may
have had a level of disability not adjusted for through
the CRGs. Examples of SMS include members receiving
day treatment, residential treatment, case management
services, and special school services covered by the De-
partment of Education. These types of services can con-
tribute significantly to a member’s total expenditures.
After evaluation of statistical distributions for these ser-
vices, members with SMS expenditures over $500 during
the 12-month study period were identified by a binomial
(0/1) variable.
During model development, it was determined that a
practice’s percentage of total members covered by Me-
dicaid was a statistically significant predictor of higher
total expenditures. Practices in Vermont varied consider-
ably in their percentage of members who were covered
by Medicaid. Therefore, the full risk-adjustment model
included a practice’s percent Medicaid for each Medicaid
enrollee in the practice.
Given widely observed healthcare disparities, women
covered by Medicaid may be at higher risk for poor ma-
ternity and neonatal outcomes than women covered by
commercial plans [19–22]. To account for these differ-
ences, an interaction term was added between Medicaid
and maternity.
As was done for Medicaid, the full risk-adjustment
model identified Medicare-eligible beneficiaries through
the indicator variable: Commercial = 0, Medicaid = 0,
Medicare = 1. The model also included a variable for
“practice’s percent Medicare” for members contributing
to the practice’s percent Medicare. Using Medicare-
specific eligibility elements, “disability” (0/1) and “end-
stage renal disease” (0/1) variables also were created.
Pediatric members covered by Medicare were excluded
from the pediatric profiling due to small numbers.
Full model & the computation of risk-adjusted rates
The risk-adjustment methods used for reporting used
SAS (Version 9.3) regression methods (SAS GENMOD
procedure). The full model included age/gender stratifi-
cation groups, Blueprint-selected chronic conditions,
CRG classification, maternity status, and the additional
Medicaid and Medicare adjustors. Adjusted rates were
produced by summing the differences between each
member’s actual value and the member’s predicted
measurement from the model. Rates were weighted for
partial lengths of enrollment. Detailed descriptions of
the model’s computation of risk-adjusted rates and 95%
confidence intervals for the adult and pediatric popula-
tions are provided below.
To calculate the adjusted rate, adjusted values were
computed for each member by adding model residuals
(e) to the population grand mean yð Þ . To report the
overall adjusted rate for each practice, the mean of the
adjusted values for the members in each practice
ypractice
 
, in each HSA (y hsa), and statewide (y statewide)
were computed. The following equations represent the
models for the adult and pediatric practice profiles.
Adult model
y ¼ αþ FAGE1834ð Þβ1 þ FAGE3544ð Þβ2 þ FAGE4554ð Þβ3 þ FAGE5564ð Þβ4 þ
FAGE6574ð Þβ5 þ FAGE7584ð Þβ6 þ FAGE85PLUSð Þβ7 þ MAGE3544ð Þβ8 þ
MAGE4554ð Þβ9 þ MAGE5564ð Þβ10 þ MAGE6574ð Þβ11 þ MAGE7584ð Þβ12þ
MAGE85PLUSð Þβ13 þ MEDICAIDð Þβ14 þ MEDICAREð Þβ15 þ DUAL ELIGIBILITYð Þβ16þ
SMSð Þβ17 þ PRACTICEPERCENTMEDIð Þβ18 þ PRACTICEPERCENTMCAREð Þβ19 þ
DISABLEDð Þβ20 þ ESRDð Þβ21 þ CHRONICð Þβ22 þ CRGACUTEMINORð Þβ23 þ
CRGCHRONICð Þβ24 þ CRGSIGNIFICANTCHRONICð Þβ25 þ
CRGCANCERCATASTROPHICð Þβ26 þ MATERNITYð Þβ27 þ MATERNITY  MEDICAIDð Þβ28 þ ε
Pediatric model
y ¼ αþ FAGE0104ð Þβ1 þ MAGE0511ð Þβ2 þ FAGE0511ð Þβ3 þ FAGE1217ð Þβ4 þ
MAGE1217ð Þβ5 þ MEDICAIDð Þβ6 þ SMSð Þβ7 þ PRACTICEPERCENTMEDIð Þβ8þ
CHRONICPEDð Þβ9 þ CRGACUTEMINORð Þβ10 þ CRGCHRONICð Þβ11 þ

























for all members equals the grand meanð Þ
where:
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 α is the intercept
 ε is the error term
 ŷ is the predicted value from the regression model
for each member
 e is the residual
 MMA is the average enrollment for each participant
(i.e., the cumulative member months of enrollment
during the year divided by 12)
 Subscript i indicates a value for an individual
member
For practice-level reporting, 95% confidence intervals
were generated based on the standard error of the mean.
For utilization measures (e.g., inpatient hospitalizations),
the Poisson distribution was utilized. The outlier cap-
ping and risk-adjustment models were run separately for
each individual expenditure and utilization measure re-
ported to practices.
Outcome measures
Blueprint practice profiles reported included 27 expend-
iture, 15 utilization, 10 HEDIS, and 5 additional National
Quality Forum (NQF) endorsed measures. This study fo-
cused on four measures for the adult and pediatric prac-
tice reporting: (1) total expenditures per capita, (2) total
expenditures per capita excluding SMS, (3) total Re-
source Use Index excluding SMS, and (4) a quality com-
posite measure constructed from HEDIS measures
(described below). Total expenditures were based on the
allowed amount on claims, which includes both the plan
payments and the member’s out-of-pocket payments
(i.e., deductible, coinsurance, and copayment). For en-
hanced expenditure parity across payers, an additional
total expenditures measure — this time excluding SMS
costs — was also examined. Within the Medicaid popu-
lation, SMS represented 26% of adult Medicaid popula-
tion expenditures and 61% of pediatric Medicaid
population expenditures.
Because pricing and reimbursement can vary, total
expenditure measures do not provide a measure of
actual consumption of resources (i.e., the actual fre-
quency and intensity of all services used). Therefore,
Blueprint used a measure of overall resource use: the
total Resource Use Index (RUI), which is based on
the NQF-endorsed measure (NQF #1598) Total Care
Relative Resource Values (TCRRVs). The measure
was implemented by applying HealthPartners’ Total
Cost of Care (TCOC) software to the claims data
[23]. The resulting standardized relative RUI was in-
cluded to measure aggregate resource consumption
across all components of care (i.e., inpatient, out-
patient facility, professional, and pharmacy). The RUI
for each practice was calculated by dividing the ad-
justed TCRRV rate by the statewide TCRRV rate.
Since the TCRRVs do not include many of the spe-
cial Medicaid services, these services were excluded
from the RUI.
Effective and preventive care measures were produced by
applying NCQA HEDIS specifications to the APCD data. A
composite adult measure was constructed at the practice
level using the practice average for three HEDIS measures:
comprehensive diabetes care hemoglobin A1c testing,
breast cancer screening, and imaging studies for low back
pain. A composite pediatric measure was constructed using
the practice average for three HEDIS measures: well-child
visits, appropriate testing for pharyngitis, and appropriate
treatment for upper respiratory infection. These measures
were a subset of six adult and four pediatric HEDIS mea-
sures available in the profile data and were selected based
on sufficient sample size at the practice level for statistical
reliability and to ensure that no focus area was over-
weighted (e.g., limiting cancer screening measures to a sin-
gle measure). Rates for HEDIS measures were not risk
adjusted, and NCQA provides no recommendations for risk
adjustment.
Comparing risk-adjustment models
The following risk-adjustment models were compared:
 No adjustment
 Age and gender (no interaction)
 Age and gender (no interaction) and CRGs
 Full model (includes age, gender, CRGs, maternity,
and payer-specific variables)
At the patient level, the percentage of variance ex-
plained by each model was evaluated using the re-
gression r2. The relative difference between models
was evaluated using the log-likelihood ratio test. At
the practice level, each model’s results were evaluated
using the coefficient of variation (CV).
Results
During 2014, an average of 283,153 adult patients and
78,162 pediatric patients were attributed to patient-
centered medical homes in the Blueprint program. Blue-
print delivered 102 adult and 56 pediatric comparative
primary care practice profiles to medical homes that met
a minimum volume threshold of 300 patients.
For the adult “whole population,” mean total expendi-
tures were $7297, while mean expenditures excluding
SMS were $6941. For the pediatric “whole population,”
mean total expenditures were $3062, while mean expen-
ditures without SMS were $1599. For the “whole popula-
tion,” SMS represented 5% of adult expenditures and
52% of pediatric expenditures.
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Practice-level variation in demographic, health status, &
payer predictors
Results revealed substantial variation across Blueprint
primary care practices regarding payer mix, demograph-
ics, and health status of the patient population. Tables 1
and 2 provide descriptive statistics for the adult and
pediatric populations including mean and range of prac-
tice size, age, and proportions for gender, CRGs, targeted
chronic conditions, maternity status (adult only, Table 1),
and Medicaid and Medicare status. The results also de-
scribe practice-level variation. Based on coefficients of
variation, practices in the adult population varied less on
age (9.8) and more on patients with maternity (81.6),
special Medicaid services (67.0), Medicare dual-eligible
status (48.3), and significant chronic conditions CRG
(42.4) (in descending order). For the pediatric popula-
tion, practices varied less on age (8.4) and more on sig-
nificant chronic conditions CRG (46.9) special Medicaid
services (35.2), patients with Medicaid (27.7), and
chronic conditions CRG (24.5) (in descending order).
Comparing risk-adjustment models
Comparative results for each risk-adjustment model are
provided in Table 3. The model for total expenditures
for the adult population resulted in an r2 of 0.028 when
adjusted for only age and gender. The r2 increased to
0.265 with the addition of CRGs and to 0.293 in the full
model. A similar pattern for the r2 was found for expen-
ditures excluding SMS and for total resource use exclud-
ing SMS. The log-likelihood ratio test indicated that the
model differences were statistically significant. For total
expenditures at the practice level for the adult popula-
tion, the no-adjustment model had the highest practice-
level variation as measured by the coefficient of variation
(18.5) compared to the age and gender model (14.8); the
age, gender, and CRG model (13.0); and the full model
(11.7). Again, a similar pattern for the CV was found for
expenditures excluding SMS and for total resource use
excluding SMS.
The model for total expenditures for the pediatric
population resulted in an r2 of 0.008 when adjusted for
only age and gender. The r2 increased to 0.253 with the
addition of CRGs and to 0.352 in the full model. A simi-
lar pattern was found for expenditures excluding SMS
and total resource use excluding SMS. As with the adult
comparisons, the log-likelihood ratio test for pediatrics
indicated that the model differences were statistically
significant. For total expenditures at the practice level
Table 1 Vermont Blueprint for Health Practice Variation in Demographics, Health Status, & Payer Mix – Adult Population, CY2014
Metric Patient-Level Variation (N = 283153) Practice-Level Variation (N = 102)
Mean Mean SD CV Median IQR (25%) IQR (75%) Min. Max.
Practice Size N/A 2699.7 2010.2 74.5 2233.0 1272 3578 352 10756
Age (in Years) 50.0 52.0 5.1 9.8 51.7 49.1 53.5 40.1 67.7
Gender = Male 45.1% 44.9% 7.1% 15.9 46.1% 42.3% 48.7% 9.3% 58.6%
Clinical Risk Group
Healthy Reference group
Acute/Minor 19.9% 19.7% 2.5% 12.5 19.8% 18.3% 21.1% 13.2% 26.2%
Chronic 24.1% 24.8% 3.9% 15.5 25.0% 22.5% 27.0% 14.5% 35.4%
Significant chronic 12.4% 13.4% 5.7% 42.4 12.5% 9.7% 15.0% 2.1% 36.3%
Cancer or catastrophic 1.4% 1.5% 0.7% 43.5 1.4% 1.2% 1.7% 0.0% 4.3%
Targeted chronic conditions 43.9% 44.8% 8.0% 17.8 44.9% 39.7% 49.9% 17.6% 65.5%
Maternity 1.6% 1.5% 1.3% 81.6 1.3% 1.0% 1.7% 0.0% 10.8%
Medicaid 18.8% 19.0% 9.1% 48.1 18.4% 13.0% 25.7% 1.0% 47.6%
Special Medicaid services 3.8% 3.6% 2.4% 67.0 3.2% 2.2% 4.9% 0.0% 14.9%
Medicare 26.3% 29.2% 11.2% 38.3 28.8% 23.9% 34.3% 0.0% 63.3%
Medicare dual eligible 6.3% 6.8% 3.3% 48.3 6.9% 4.6% 8.9% 0.0% 15.1%
Medicare disabled 6.8% 7.2% 3.1% 43.6 7.0% 5.2% 9.0% 0.0% 15.9%
Medicare End-Stage Renal Disease (ESRD) 0.08% 0.08% 0.09% 109.3 0.06% 0.00% 0.11% 0.00% 0.48%
All percentages use the whole population as denominator and are not specific to payer (e.g., Special Medicaid Services for Medicaid). Examples of special
Medicaid services include patients receiving day treatment, residential treatment, case management services, and special school services covered by the
Department of Education. Clinical Risk Groups utilize a hierarchy to classify a patient into one and only one CRG for the year. Example conditions include Acute or
Minor Chronic (e.g., acute ear, nose or throat condition or minor join pain), Moderate Chronic (e.g., diabetes or moderate chronic joint pain), Significant Chronic
(e.g., diabetes with other comorbid conditions such as CHF or COPD), and Cancer or Catastrophic (e.g., malignant breast cancer, HIV, cystic fibrosis, muscular
dystrophy, quadriplegia). Target Conditions include asthma, chronic obstructive pulmonary disease, congestive heart failure, ischemic heart disease, hypertension,
depression, diabetes, and attention deficit disorder
SD Standard deviation, CV Coefficient of variation, IQR Interquartile range
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for the pediatric population, the no-adjustment model
had a higher CV (23.4) compared to the full model
(11.4). Again, a similar pattern for the CV was found for
expenditures excluding SMS and for total resource use
excluding SMS.
The HEDIS composite measures were not risk ad-
justed. The practice-level coefficient of variation for the
adult (5.4) and pediatric (7.8) populations were both
lower than variation in the expenditure or RUI
measures.
Primary care practice-level variation & associations
Compared with the no-adjustment model, the full model
showed reduced variation at the practice level. For the
adult population, the practice-level range in per person
annual expenditures without adjustment ($3506–$13,056)
was reduced in the full model ($5113–$9666). For the
pediatric population, the same trend held true, with the
practice-level range in per-person annual expenditures
without adjustment ($1112–$2193) demonstrating a re-
duction in the full model ($1331–$2002).
When stratifying the practices’ average per person an-
nual expenditures excluding SMS into quintiles for both
the adult and pediatric populations, the results (Table 4)
demonstrated a reduction in the variability between
practices in the full model compared to the no-
adjustment model. Comparing the first (i.e., the lowest
average annual expenditures) and fifth (i.e., the highest
average annual expenditures) quintiles, the full model
decreased the range by $1335 (37%) for the adult
population practices and by $238 (37%) for the pediatric
population practices relative to non-risk-adjusted rates.
In addition, a large proportion of practices shifted into a
different expenditure quintile in the full model com-
pared to no adjustment – 77% for adult population prac-
tices and 54% for pediatric population practices.
Using the practice-level risk-adjusted expenditures,
total Resource Use Index (RUI) rates, and HEDIS com-
posite measures, Figs. 1, 2, 3 and 4 compare practice-
level variation between the no-adjustment and full
models.
Figure 1 displays the adult population’s practice-level
association between total expenditures per capita and
total Resource Use Index (both excluding SMS). As mea-
sured by the practice-level coefficient of variation, there
was less variation in the full model adjustment for ex-
penditures (12.1 vs. 19.1) and RUI (11.5 vs 22.4). The re-
sults also indicate that utilization is significantly
associated with expenditures at the practice level for the
full model (r2 .83, p < .001).
Figure 2 displays the adult population’s practice-
level association between the HEDIS composite meas-
ure and Total Expenditures Per Capita Excluding
SMS. Because the HEDIS composite is not risk ad-
justed the coefficient of variation (5.4) was identical
for both models. While the no-adjustment model in-
dicated a moderate positive association between
HEDIS composite, the full model indicated a negative
association between HEDIS composite and expendi-
tures (r2 .12, p < .001). This underscores the potential
Table 2 Vermont Blueprint for Health Practice Variation in Demographics, Health Status, & Payer Mix – Pediatric Population, CY2014
Metric Patient Level (N = 78162) Practice-Level Variation (N = 56)
Mean Mean SD CV Median IQR (25%) IQR (75%) Min. Max.
Practice size NA 1264.7 1109.7 87.7 880.5 455 1678 317 5303
Age (in years) 9.1 9.4 0.8 8.4 9.3 8.7 10.1 7.7 11.1
Gender = Male 51.2% 51.0% 2.4% 4.8 51.1% 49.6% 52.8% 44.9% 55.4%
Clinical risk groups
Healthy Reference group
Acute/Minor 15.8% 16.1% 2.1% 12.7 16.1% 15.0% 17.4% 10.9% 21.0%
Chronic 8.8% 8.6% 2.1% 24.5 8.3% 7.2% 9.6% 5.0% 16.6%
Significant chronic 1.1% 1.0% 0.5% 46.9 1.0% 0.6% 1.3% 0.2% 2.3%
Cancer or catastrophic 0.2% 0.2% 0.1% 92.4 0.1% 0.0% 0.3% 0.0% 0.7%
Targeted chronic conditions 20.0% 20.2% 3.9% 19.3 19.9% 17.5% 22.9% 12.2% 30.3%
Medicaid 53.8% 54.3% 15.0% 27.7 56.6% 43.6% 64.8% 24.8% 82.9%
Special Medicaid services 18.1% 18.3% 6.4% 35.2 18.3% 13.2% 22.0% 6.9% 33.4%
All percentages use the whole population as denominator and are not specific to payer (e.g., Special Medicaid Services for Medicaid). Examples of special
Medicaid services include patients receiving day treatment, residential treatment, case management services, and special school services covered by the
Department of Education. Clinical Risk Groups utilize a hierarchy to classify a patient into one and only one CRG for the year. Example conditions include Acute or
Minor Chronic (e.g., acute ear, nose or throat condition or minor join pain), Moderate Chronic (e.g., diabetes or moderate chronic joint pain), Significant Chronic
(e.g., diabetes with other comorbid conditions such as CHF or COPD), and Cancer or Catastrophic (e.g., malignant breast cancer, HIV, cystic fibrosis, muscular
dystrophy, quadriplegia). Target Conditions include asthma, chronic obstructive pulmonary disease, congestive heart failure, ischemic heart disease, hypertension,
depression, diabetes, and attention deficit disorder
SD Standard deviation, CV Coefficient of variation, IQR Interquartile range
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for differential interpretation of results when risk-
adjustment is applied. In this case, using the full
model suggests the possibility that practices with im-
proved higher HEDIS composite score had lower
expenditures.
Figures 3 and 4 display no-adjustment and full-
model adjustment results at the practice level for the
pediatric population. Like the adult population, there
was less variation in in the full model than the no
adjustment model in the coefficient of variation for
expenditures (9.3 vs. 15.0) and RUI (9.0 vs 17.0) and
strong association between utilization and expendi-
tures in the full model results (r2 .67, p < .001). Unlike
the adult model, no association between HEDIS com-
posite and expenditures was found in the full model
results (r2 .01, p = .458).
Table 3 Vermont Blueprint for Health Risk-Adjustment Model Comparisons & Resulting Practice Level Coefficient of Variation,
CY2014
Model Adult Model Pediatric Model
r2 D = Log-Likelihood
Ratio (p-value)
Model Adjusted Practice Level
Coefficient of Variation
r2 D = Log-Likelihood
Ratio (p-value)
Model Adjusted Practice Level
Coefficient of Variation
Total expenditures
No adjustment N/A 18.5 N/A 23.4
Age and gender 0.028 8102 (p < .001) 14.8 0.008 647 (p < .001) 24.3
Age, gender, and
CRG
0.265 79231 (p < .001) 13.0 0.253 22138 (p < .001) 19.3
Full model 0.293 10884 (p < .001) 11.7 0.352 11092 (p < .001) 11.4
Total expenditures
excluding SMS
No adjustment N/A 19.1 N/A 15.0
Age and gender 0.038 11116 (p < .001) 14.2 0.007 524 (p < .001) 15.3
Age, gender, and
CRG
0.270 78242 (p < .001) 14.3 0.288 25982 (p < .001) 9.9
Full model 0.285 5779 (p < .001) 12.1 0.302 1622 (p < .001) 9.3
Total resource use
excluding SMS
No adjustment N/A 22.4 N/A 17.0
Age and gender 0.045 12904 (p < .001) 17.3 0.007 561 (p < .001) 17.4
Age, gender, and
CRG
0.266 74684 (p < .001) 13.6 0.289 26054 (p < .001) 11.7




The r2 represents the percentage explained by the model at the patient level. The mode-adjusted practice-level coefficient of variation represents the degree of
variability in rates between practices at the practice level, with a lower value indicating reduced variation
Table 4 Vermont Blueprint for Health Practice-Level Comparison of Mean Total Expenditures Excluding Special Medicaid Services
(SMS) – No Adjustment vs. Full Model, CY2014
Total Expenditures Excluding Special
Medicaid Services (SMS) –Quintiles
Adult Practices (N = 102) Pediatric Practices (N = 56)
No-Adjustment Mean Full-Model Mean No-Adjustment Mean Full-Model Mean
1 $5555 $5812 $1301 $1415
2 $6464 $6424 $1454 $1517
3 $7093 $6823 $1578 $1596
4 $7886 $7189 $1738 $1664
5 $9179 $8101 $1949 $1825
For adult practices, compared to the no-adjustment model, the full model changed the quintile for 79 (77%) of the practices, with 41 practices shifting to a higher
expenditure quintile and 38 changing to a lower expenditure quintile (23 remained in the same quintile). For pediatric practices, compared to the No-Adjustment
Model, the Full Model changed the quintile for 30 (54%) of the practices, with 16 practices moving to a higher expenditure quintile and 14 changing to a lower
expenditure quintile (26 remained in the same quintile). Examples of special Medicaid services include patients receiving day treatment, residential treatment, case
management services, and special school services covered by the Department of Education
Finison et al. BMC Health Services Research  (2017) 17:58 Page 8 of 13
Fig. 1 Vermont Blueprint for Health Practice-Level Comparison: Total Expenditures vs. Total Resource Use Index (RUI) Excluding Special Medicaid
Services (SMS) – Adult, No Adjustment vs. Full Model, CY2014
Fig. 2 Vermont Blueprint for Health Practice-Level Comparison: Total Expenditures Excluding Special Medicaid Services (SMS) vs. Healthcare
Effectiveness and Data Information Set (HEDIS) Composite – Adult, No Adjustment vs. Full Model, CY2014
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Fig. 3 Vermont Blueprint for Health Practice-Level Comparison: Total Expenditures vs. Total Resource Use Index (RUI) Excluding Special Medicaid
Services (SMS) – Pediatric, No Adjustment vs. Full Model, CY2014
Fig. 4 Vermont Blueprint for Health Practice-Level Comparison: Total Expenditures Excluding Special Medicaid Services (SMS) vs. Healthcare
Effectiveness and Data Information Set (HEDIS) Composite – Pediatric, No Adjustment vs. Full Model, CY2014
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Discussion
This study assessed risk-adjustment models in support
of a “whole-population” approach to measuring and
comparing healthcare expenditures and utilization at the
practice level. The findings suggest that a more complete
risk-adjustment model is appropriate for all-payer,
“whole-population” analytics when comparing outcomes
at the practice level; this study’s results are in line
with a limited number of studies that support the
need for risk adjustment. Pope, et al. demonstrated
the importance of adjusting for additional variables
beyond age and gender for improving the prediction
of expenditures [24] However, that study was limited
to Medicare data. Another study concluded that risk-
adjusted performance measures based on multi-payer
claims data were feasible for the assessment of per-
formance and bundled payments to medical homes
[25]. Additional studies that applied and compared
robust risk-adjustment methods for “whole popula-
tions” were not found, indicating a gap that this
paper begins to fill.
This risk-adjustment method has been used in the
comparative practice profiles developed by the Blueprint,
which evaluates practices’ whole populations relative to
other practices and to HSA and state outcomes. Follow-
ing the initial work with state stakeholders on the devel-
opment of risk-adjustment methods, these profiles,
which use the full risk-adjustment model, have been rep-
licated semi-annually for several years, consistently
yielding similar results for practices.
The adult and pediatric populations were addressed
separately due to the differences in the health status,
utilization, and expenditure patterns specific to each
population. For example, within the pediatric population,
more than half of expenditures for the combined com-
mercial and Medicaid populations were for special Me-
dicaid services (SMS). It should be noted, however, that
while this variable was a significant predictor in the Ver-
mont model, coverage of these non-medical social sup-
port services may vary by state [26]. Spending on social
services and public health as a percent of state gross do-
mestic product (GDP) varies significantly by state, with
Vermont ranking highest in the country based on a re-
cent study [27].
Practice-level results indicated that practices varied
significantly in patient demographics, health status, and
payer mix, so additional payer-specific factors were
included in the model to control for these factors. Risk-
adjusting for these differences reduced the variability
between practices in reported expenditures and total re-
source use measures. As measured by r2 and the log-
likelihood ratio test, the predictive ability of the full
model over the no-adjustment and simpler models was
demonstrated. Measured at the practice level by the
coefficient of variation, the reduction in variation be-
tween practices using the full model was substantial. For
the adult population, a modest practice-level association
between higher composite HEDIS preventive and effect-
ive care measures and lower per capita expenditures was
found for the full-model results but not for the no-
adjustment model.
The Blueprint primary care practice profiles are dis-
seminated semi-annually to participating practices.
While practice-specific results have not been made pub-
licly available to date, the profiles have provided a tool
for the Blueprint program and participating practices to
understand expenditure, utilization, and quality of care
outcomes relative to other practices in their HSA and
across the state. The profiles have contributed to a new
level of dialogue and data use across practices and orga-
nizations and are routinely used to guide quality and co-
ordination initiatives in each HSA.
This study used a parsimonious model. Additional so-
cioeconomic factors (e.g., housing, income, race, ethni-
city, etc.) as well as self-reported health status may
improve the model, but were not available in the APCD.
A practice’s percent Medicaid served as a proxy for the
socioeconomic status of patients in the practice. This
paper reports actual payments (i.e., allowed amount)
which may be subject to regional variation in prices [28]
and a Resource Use Index that is a price-neutral com-
parison of resource consumption.
A sample of HEDIS measures were selected for this
study to create a simple, overall composite measure. The
purpose of this study was not to examine a larger sam-
pling of quality measures, but instead to evaluate and
demonstrate that there can be a change in the relation-
ship between quality and expenditure measures when
risk adjustment is applied to the expenditure measures.
Strong correlations between quality measures and ex-
penditure measures also were not found in other studies
[29]. Debate continues at the national level as to
whether effective and preventive care quality measures
should be risk adjusted. Since these measures represent
recommended care according to clinical guidelines, the
case can be made to not risk-adjust these measures in a
“whole-population” system.
This study did not compare or make recommenda-
tions regarding health status software or calculations.
Rather, it used the commercially available 3M™ CRG sys-
tem that performs well in identifying conditions associ-
ated with cost across the age spectrum. Other studies
have compared different health status software systems
[10, 18]. All claims-based systems have a limitation when
there is a correlation between visits intensity and illness
reported — that is, patients with more visits tend to ap-
pear “sicker” or have more diagnoses than similar people
treated in less intensive environments [30].
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This was a quantitative study. Formal qualitative re-
search to use focus groups, interviews, or survey prac-
tices to determine their perspectives on what other
drivers of differences between high-cost practices versus
low-cost practices may prove beneficial.
Conclusions
This study demonstrated the feasibility of combining
populations covered by commercial, Medicaid, and
Medicare into a single “whole-population” measure-
ment system. The study demonstrated that primary
care practices varied significantly in demographics,
health status, payer mix, and patients receiving social
support services from Medicaid for their adult and
pediatric populations. It also indicated that an en-
hanced risk-adjustment model improved the predictive
power and reduced practice-level variation for total
expenditure and utilization measures reporting, which
has helped to gain acceptance among providers and
other stakeholders in contrast to single-payer reports
on practice subpopulations. In light of efforts taking
place across the United States to move towards an ac-
countable health system, the “whole-population” measure-
ment approach may have value to accountable care
organizations, policymakers, and consumers alike.
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